skip to content
Clopidogrel versus other antiplatelet agents in the secondary prevention of vascular events in adults with cerebrovascular disease : clinical and cost-effectiveness analyses Preview this item
ClosePreview this item
Checking...

Clopidogrel versus other antiplatelet agents in the secondary prevention of vascular events in adults with cerebrovascular disease : clinical and cost-effectiveness analyses

Author: Srabani Banerjee; Canadian Agency for Drugs and Technologies in Health.
Publisher: Ottawa : Canadian Agency for Drugs and Technologies in Health = Agence canadienne des médicaments et des technologies de la santé, 2009.
Series: Technology report (Canadian Agency for Drugs and Technologies in Health : Online), 123.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
The aim of this report is to compare clopidogrel with other antiplatelet agents for the secondary prevention of vascular events in adults with cerebrovascular events (ischemic stroke or transient ischemic attack). This includes assessing the optimal duration and timing of clopidogrel treatment.
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Additional Physical Format: Print version:
Banerjee, Srabani.
Clopidogrel versus Other Antiplatelet Agents in the Secondary Prevention of Vascular Events in Adults with Cerebrovascular Disease : Clinical and Cost-Effectiveness Analyses.
Ottawa : Canadian Agency for Drugs and Technologies in Health, ©2009
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Srabani Banerjee; Canadian Agency for Drugs and Technologies in Health.
ISBN: 9781926680354 1926680359 1926680340 9781926680347
OCLC Number: 505275896
Notes: Publisher's Web site: http://cadth.ca.
Description: 1 online resource.
Contents: Executive summary --
Acronyms and abbreviations --
1. Introduction --
1.1. Background and setting in Canada --
1.2. Overview of technology --
2. Issue --
3. Objectives --
4. Clinical review --
4.1. Methods. 4.1.1. Literature searches; 4.1.2. Selection criteria; 4.1.3. Selection method; 4.1.4. Data extraction strategy; 4.1.5. Strategy for validity assessment; 4.1.6. Data analysis methods --
4.2. Results. 4.2.1. Quantity of research available; 4.2.2. Study characteristics; 4.2.3. Data analyses and synthesis; 4.2.4. Guidelines review --
5. Economic analysis --
5.1. Review of economic studies: methods. 5.1.1. Literature searches; 5.1.2. Selection criteria; 5.1.3. Selection method; 5.1.4. Data extraction strategy; 5.1.5. Strategy for validity assessment; 5.1.6. Data analysis methods --
5.2. Review of economic studies: results --
5.3. Primary economic evaluation: methods. 5.3.1. Type of economic evaluation; 5.3.2. Target population; 5.3.3. Comparator and interventions; 5.3.4. Perspective; 5.3.5. Time horizon; 5.3.6. Effectiveness; 5.3.7. Modelling; 5.3.8. Resource use and costs; 5.3.9. Valuing outcomes; 5.3.10. Discount rate; 5.3.11. Variability and uncertainty; 5.3.12. Equity --
5.4. Primary economic evaluation: results. 5.4.1. Analysis and results; 5.4.2. Results of variability analysis; 5.4.3. Results of uncertainty analysis; 5.4.4. Results of probabilistic analysis.
Series Title: Technology report (Canadian Agency for Drugs and Technologies in Health : Online), 123.
Responsibility: Srabani Banerjee [and others].
More information:

Abstract:

The aim of this report is to compare clopidogrel with other antiplatelet agents for the secondary prevention of vascular events in adults with cerebrovascular events (ischemic stroke or transient ischemic attack). This includes assessing the optimal duration and timing of clopidogrel treatment.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.